LENZ (LENZ Therapeutics) ROE % Adjusted to Book Value : -6.21% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics ROE % Adjusted to Book Value?

LENZ Therapeutics's ROE % for the quarter that ended in Dec. 2024 was -24.14%. LENZ Therapeutics's PB Ratio for the quarter that ended in Dec. 2024 was 3.89. LENZ Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -6.21%.

LENZ Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for LENZ Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics ROE % Adjusted to Book Value Chart

LENZ Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

-22.97

LENZ Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						-	-44.00	-9.04	-6.61	-6.21

Competitive Comparison of LENZ Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, LENZ Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LENZ Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where LENZ Therapeutics's ROE % Adjusted to Book Value falls into.

LENZ Therapeutics ROE % Adjusted to Book Value Calculation

LENZ Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-89.37%	/	3.89
	=	-22.97%

LENZ Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-24.14%	/	3.89
	=	-6.21%

LENZ Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014

Website

https://www.lenz-tx.com

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.